Zhao, Y., Wang, L., Mao, A., Zhu, W., Zhang, T., Pan, Q., Wang, L. (2026). Tislelizumab combined with donafenib and GEMOX as first-line treatment for advanced biliary tract cancer: A single-arm, phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4110